Related Experiment Video
Updated: Jun 19, 2026
09:53
An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
Published on: August 25, 2017
c-Kit (CD117) expression in classic Kaposi's sarcoma
N O Kandemir1, B D Gun, B Bahadir
1Department of Pathology, Faculty of Medicine, Zonguldak Karaelmas University, Zonguldak, Turkey. niluferkandemir@yahoo.com
Clinical and Experimental Dermatology
|October 31, 2009
Summary
Classic Kaposi's sarcoma (KS) shows high c-Kit expression, but this does not correlate with Human Herpesvirus 8 (HHV8) presence or clinicopathological features. Further research is needed to understand c-Kit's role in KS pathogenesis.
Area of Science:
- Oncology
- Virology
- Pathology
Background:
- Kaposi's sarcoma (KS) is a vascular neoplasm linked to Human Herpesvirus 8 (HHV8).
- HHV8 infection can induce c-Kit, a tyrosine receptor kinase, in cells.
- Understanding c-Kit's role in KS is crucial for disease management.
Purpose of the Study:
- To examine c-Kit expression in classic Kaposi's sarcoma.
- To determine the association between c-Kit expression, clinicopathological parameters, and HHV8.
- To clarify the role of HHV8 latency-associated nuclear antigen-1 in this context.
Main Methods:
- Immunohistochemistry was used to detect c-Kit and HHV8 in 35 classic KS tissue samples.
- Clinicopathological data, including tumor stage and patient demographics, were analyzed.
- Correlation analysis was performed between c-Kit expression and various parameters.
Main Results:
- c-Kit immunoreactivity was observed in 22 out of 35 (63%) classic KS cases.
- HHV8 immunoreactivity was detected in all studied cases.
- No significant correlation was found between c-Kit expression and clinicopathological parameters or HHV8 immunoreactivity.
Conclusions:
- Classic Kaposi's sarcoma exhibits a high prevalence of c-Kit immunoreactivity.
- c-Kit expression in classic KS is independent of HHV8 status.
- The study highlights a potential role for c-Kit in KS, but its direct link to HHV8 requires further investigation.
More Related Videos
Related Concept Videos
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...